menu
    • menu

    Company profile for HI-Bio

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HI-Bio™ was founded on the idea that therapies for immune-mediated diseases (IMDs) have the potential to achieve better results for patients. Many IMDs stem from the dysfunction of cells that make up the immune system, including plasma cells, neutrophils, mast cells and more. These cells are responsible for critical functions and processes. HI-Bio’s programs apply a precision medicine approach to target, modulate or dep...
    HI-Bio™ was founded on the idea that therapies for immune-mediated diseases (IMDs) have the potential to achieve better results for patients. Many IMDs stem from the dysfunction of cells that make up the immune system, including plasma cells, neutrophils, mast cells and more. These cells are responsible for critical functions and processes. HI-Bio’s programs apply a precision medicine approach to target, modulate or deplete these cellular drivers of disease with therapeutics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HI-BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Francisco, California
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hibio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biogen Returns To Its Roots With A West Coast Immunology Outpost
    Biogen Returns To Its Roots With A West Coast Immunology Outpost

    18 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/how-biogen-returning-its-roots-west-coast-immunology-outpost

    FIERCE BIOTECH
    18 Nov 2025
    Share Share
    Biogen Completes Acquisition of HI-Bio
    Biogen Completes Acquisition of HI-Bio

    03 Jul 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-07-03/biogen-completes-acquisition-of-hi-bio/9769

    CONTRACT PHARMA
    03 Jul 2024
    Share Share
    Hi-Bio Felzartamab Kidney Rejection: Positive Phase 2 Results In Recipients
    Hi-Bio Felzartamab Kidney Rejection: Positive Phase 2 Results In Recipients

    25 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hi-bio-announces-positive-results-from-phase-2-study-of-felzartamab-for-late-antibody-mediated-rejection-in-kidney-transplant-recipients-302155655.html

    PR NEWSWIRE
    25 May 2024
    Share Share
    Hi-Bio Felzartamab Igan Positive: Phase 2 Ignaz Interim Results At Era
    Hi-Bio Felzartamab Igan Positive: Phase 2 Ignaz Interim Results At Era

    24 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hi-bio-presents-positive-interim-results-from-phase-2-ignaz-study-of-felzartamab-in-iga-nephropathy-at-61st-european-renal-association-era-congress-302155120.html

    PR NEWSWIRE
    24 May 2024
    Share Share
    Biogen in up to $1.8 bln deal as rare diseases take center stage
    Biogen in up to $1.8 bln deal as rare diseases take center stage

    23 May 2024

    // REUTERS

    https://www.reuters.com/markets/deals/biogen-buy-human-immunology-biosciences-up-18-bln-deal-2024-05-22/

    REUTERS
    23 May 2024
    Share Share
    HI-Bio to Present at the 61st European Renal Association (ERA) Congress
    HI-Bio to Present at the 61st European Renal Association (ERA) Congress

    29 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hi-bio-to-present-at-the-61st-european-renal-association-era-congress-302103190.html

    PR NEWSWIRE
    29 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search